Form 4 for BDX Becton Dickinson
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-26 · accession 0001628280-25-058843 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2025-12-26 | BDX | Feld Michael | EVP, CRO, Pres. Life Sciences | S - Sale | $196.08 | -74 | 16.5K | -0.4% | -$14.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-26 | S | D | 74 | $196.08 | 16,506 | D | — | — |